#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
preLekára.sk / Journals / Journal of Czech Physicians / 2019 - 5

Significance of sleep and sleep disorders in psychiatry

Česká verzia

Authors: Petr Smolík
Authors place of work: Psychiatrická ordinace, Praha 5
Published in the journal: Čas. Lék. čes. 2019; 158: 193-199
Category: Review Article

Summary

Sleep disorders are an integral part of all mental disorders. They can also be an important part of their etiopathogenesis. The current multidimensional model of mental disorders is inextricably linked to sleep research. Increasing knowledge about the neurophysiology of the sleep process and etiopathogenetic factors of sleep disorders helps to gradually approach the understanding of the etiopathogenesis of mental disorders.

Keywords:

sleep disorders – mental disorders – classification of sleep disorders – pharmacotherapy of insomnia

Zdroje
    1. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th revision, Version 2016. World Health Organization, Geneva, 2016.
    2. Smolík P. Poruchy spánku u duševních poruch. In: Nevšímalová S, Šonka K (eds.). Poruchy spánku a bdění (2. vyd.). Galén, Praha, 2007: 303–323.
    3. American Academy of Sleep Medicine. The International Classification of Sleep Disorders, 3rd ed. AASM, Darien, 2014.
    4. Mohr P. Co přinese nová klasifikace MKN-11? Česká a slovenská psychiatrie 2017; 113: 147–148.
    5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. APA, Washington, DC, 2013.
    6. Overbeek T, van Diest R, Schruers K et al. Sleep complaints in panic disorder patients. J Nerv Ment Dis 2005; 193: 488–493.
    7. Merritt-Davis O, Balon R. Nocturnal panic: biology, psychopathology, and its contribution to the expression of panic disorder. Depress Anxiety 2003; 18: 221–227.
    8. Johnson PL, Truitt W, Fitz SD et al. A key role for orexin in panic anxiety. Nat Med 2010; 16 (1): 111–115.
    9. Craske MG, Lang AJ, Aikins D, Mystkowski JL. Cognitive behavioral therapy for nocturnal panic. Behav Ther 2005; 36 (1): 43–54.
    10. Kasper S, Iglesias-García C, Schweizerm E et al. Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder. Int J Neuropsychopharmacol 2014;17: 685–695.
    11. Hajda M, Kamarádová D, Praško J. Léčba generalizované úzkostné poruchy pomocí pregabalinu. Psychiatrie pro praxi 2015; 16: 101–104.
    12. Buckner JD, Bernert RA, Cromer KR et al. Social anxiety and insomnia: the mediating role of depressive symptoms. Depress Anxiety 2008; 25: 124–130.
    13. Sareen J, Stein M. A review of the epidemiology and approaches to the treatment of social anxiety disorder. Drugs 2000; 59: 497–509.
    14. Clark DM, Ehlers A, McManus F et al. Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial. J Consult Clin Psychol 2003; 71(6): 1058–1067.
    15. Southwick SM, Paige S, Morgan CA et al. Neurotransmitter alterations in PTSD: catecholamines and serotonin. Semin Clin Neuropsychiatry 1999, 4(4): 242–248.
    16. Devilbiss DM, Waterhouse BD, Berridge CW, Valentino R. Corticotropin-releasing factor acting at the locus coeruleus disrupts thalamic and cortical sensory-evoked responses. Neuropsychopharmacology 2012; 37: 2020–2030.
    17. Pace-Schott EF, Hobson JA. The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci. 2002; 3: 591–605.
    18. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K. Depression: perspectives from affective neuroscience. Annu Rev Psychol 2002; 53: 545–574.
    19. Minkel J, Moreta M, Muto J et al. Sleep deprivation potentiates HPA axis stress reactivity in healthy adults. Health Psychol 2014; 33:1430–1434.
    20. Berk M, Williams LJ, Jacka FN et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 2013; 11: 200.
    21. Byrne EM, Heath AC, Madden PA et al. Testing the role of circadian genes in conferring risk for psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet 2014; 165 (3): 254–260.
    22. Bardwell WA, AncoliIsrael S, Dimsdale JE. Comparison of the effects of depressive symptoms and apnea severity on fatigue in patients with obstructive sleep apnea: a replication study. J Affect Disord 2007; 97: 181–186.
    23. Goel N, Rao H, Durmer JS, Dinges DF. Neurocognitive consequences of sleep deprivation. Semin Neurol 2009; 29: 320–329.
    24. Clements C, Morriss R, Jones S et al. Suicide in bipolar disorder in a national English sample, 1996–2009: frequency, trends and characteristics. Psychol Med 2013; 43: 2593–2602.
    25. Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA 2005; 293: 2528–2530.
    26. Harvey AG, Schmidt DA, Scarna A et al. Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems. Am J Psychiatry 2005; 162: 50–57.
    27. Ritter PS, Marx C, Bauer M et al. The role of disturbed sleep in the early recognition of bipolar disorder: a systematic review. Bipolar Disord 2011; 13: 227–237.
    28. Nofzinger EA, Thase ME, Reynolds CF et al. Hypersomnia in bipolar depression: a comparison with narcolepsy using the multiple sleep latency test. Am J Psychiatry 1991; 148: 1177–1181.
    29. Haffmans PM, Hoencamp E, Knegtering HJ et al. Sleep disturbance in schizophrenia. Br J Psychiatry 1994;165: 697–698.
    30. Poulin J, Chouinard S, Pampoulova T et al. Sleep habits in middle-age, non-hospitalized men and women with schizophrenia: a comparison with healthy controls. Psychiatry Res 2010; 179: 274–278.
    31. Miller BJ, Parker CB, Rapaport MH et al. Insomnia and suicidal ideation in nonaffective psychosis. Sleep 2019; 42, doi: 10.1093/sleep/zsy215.
    32. Lieberman JA, Stroup TS, McEvoy JP et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209–1223.
    33. Waters F, Hanken K, Rock D. Sleep-disordered breathing in schizophrenia: an audit. Schizophr Res 2013; 143: 393–394.
    34. Seeman MV. Sleepwalking, a possible side effect of antipsychotic medication. Psychiatr Q 2011; 82: 59–67.
    35. Faridhosseini F, Zamani A. A case report of somnambulism associated with olanzapine. Iran J Psychiatry Behav Sci 2012; 6: 72–74.
    36. Lu ML, Shen WW. Sleep-related eating disorder induced by risperidone. J Clin Psychiatry 2004; 65: 273.
    37. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. Sleep 2000; 22: 347–53.
    38. Issa FG, Sullivan CE. Alcohol, snoring and sleep apneas. J Neurol Neurosurg Psychiatry 1982; 45 :353–359.
    39. Brower KJ. Alcohol’s effects on sleep in alcoholics. Alcohol Res Health 2001; 25: 110–125.
    40. Bonnet MH, Arand DL. Caffeine use as a model of acute and chronic insomnia. Sleep 1992; 15: 526–536.
    41. Prosise GL, Bonnet MH, Berry RB, Dickel ML. Effects of abstinence from smoking on sleep and daytime sleepiness. Chest 1994; 105: 1136–1141.
    42. Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Gen Psychiatry 1986; 43: 107–113.
    43. Nicholson AN, Stone BM. Stimulants and sleep in man. Agressologie 1981; 22: 73–78.
    44. Kay DC, Eisenstein RB, Jasinski DR. Morphine effects on human REM state, waking state, and NREM sleep. Psychopharmacologia 1969; 14: 404–416.
    45. Roehrs T, Roth T. Medication and substance abuse. In: Kryger MH, Roth T (eds.). Principles and Practice of Sleep Medicine (6th ed.). Elsevier, Philadelphia, 2017: 1386.
    46. Mitler MM, Hajdukovic R, Erman MK. Treatment of narcolepsy with methamphetamine. Sleep 1993; 16: 306–317.
    47. Watson R, Hartmann E, Schildkraut JJ. Amphetamine withdrawal: affective state, sleep patterns and MHPG excretion. Am J Psychiatry 1972; 129: 262–269.
    48. Babor TF, Mendelson JH, Kuehnle J. Marihuana and human physical activity. Psychopharmacology 1976; 50: 11–19.
    49. Randall S, Johanson CE, Tancer M et al. Effects of acute 3,4-methylenedioxymethamphetamine on sleep and daytime sleepiness in MDMA users: a preliminary study. Sleep 2009; 32: 1513–1519.
    50. Smolík P. Farmakoterapie nespavosti. In: Pretl M, Smolík P. Nespavost. Centrum doporučených postupů pro praktické lékaře, Praha, 2017: 5–7.
    51. Iwase T, Kajimura N, Uchiyama M et al. Mutation screening of the human Clock gene in circadian rhythm sleep disorders. Psychiatry Res 2003; 109: 121–128.
    52. Archer SN, Robilliard DL, Skene DJ et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 2003; 26: 413–415.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental Hygienist
Článek Ke 150. výročí úmrtí Jana Evangelisty Purkyně
Článek Advance in sleep medicine and non-invasive ventilation in respiratory medicine
Článek Sleep apnea and cardiovascular disease
Článek Metabolické poruchy a spánek
Článek Docent František Novotný – poslední asistent J. E. Purkyně a „vir infelix“
Článek Zemřel profesor Josef Marek, nejskromnější Rytíř českého lékařského stavu
Článok vyšiel v časopise

Journal of Czech Physicians

Číslo 5
2019 Číslo 5
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#